Business
The AstraZeneca jab and the price of fragmented decision-making – Al Jazeera English
Experts warn authorities’ divergent policies may damage trust and increase hesitancy in countries facing shortages.
Elena Hugony was sure about one thing as she entered a COVID-19 vaccination centre in the Italian city of Palermo last week: she was not going to allow to be injected with the AstraZeneca vaccine.
Sure enough, when a healthcare worker approached her with a shot of the jab developed by the Anglo-Swedish pharmaceutical giant and the University of Oxford, the 75-year-old stood firm to her conviction. With Hugony refusing to leave, a doctor finally relented after four hours and gave her a shot of the…
-
General18 hours agoIran’s currency at record low as tensions run high
-
Noosa News24 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News22 hours agoAbusive bus driver fired by council loses appeal
-
General18 hours agoLabor to pledge $2.3 billion to subsidise home batteries